BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30244551)

  • 1. Multidisciplinary management of motor neurone disease.
    Lau FS; Brennan FP; Gardiner MD
    Aust J Gen Pract; 2018 Sep; 47(9):593-597. PubMed ID: 30244551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment approaches in motor neurone disease.
    Dharmadasa T; Matamala JM; Kiernan MC
    Curr Opin Neurol; 2016 Oct; 29(5):581-91. PubMed ID: 27454577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
    Stewart A; Sandercock J; Bryan S; Hyde C; Barton PM; Fry-Smith A; Burls A
    Health Technol Assess; 2001; 5(2):1-97. PubMed ID: 11809124
    [No Abstract]   [Full Text] [Related]  

  • 4. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC; Burke D; Pamphlett R; Kiernan MC
    J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neurone disease - caring for the patient in general practice.
    Zoing M; Kiernan M
    Aust Fam Physician; 2011 Dec; 40(12):962-6. PubMed ID: 22146323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative care for patients with motor neurone disease and their bereaved carers: a qualitative study.
    Mc Veigh C; Donaghy C; Mc Laughlin B; Dick A; Kaur K; Mc Conville J; Watson M
    BMC Palliat Care; 2019 Apr; 18(1):39. PubMed ID: 31027498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of motor neurone disease.
    Howard RS; Orrell RW
    Postgrad Med J; 2002 Dec; 78(926):736-41. PubMed ID: 12509691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nursing role in the multidisciplinary management of motor neurone disease.
    Skelton J
    Br J Nurs; 2005 Jan 13-26; 14(1):20-4. PubMed ID: 15750484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neuron disease associated with multiple myeloma.
    Koc F; Paydas S; Yerdelen D; Demirkiran M
    Int J Neurosci; 2008 Mar; 118(3):337-41. PubMed ID: 18300006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor neurone disease: progress and challenges.
    Dharmadasa T; Henderson RD; Talman PS; Macdonell RA; Mathers S; Schultz DW; Needham M; Zoing M; Vucic S; Kiernan MC
    Med J Aust; 2017 May; 206(8):357-362. PubMed ID: 28446118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supportive & palliative interventions in motor neurone disease: what we know from current literature?
    Cheng HWB; Chan KY; Chung YKJ; Choi CW; Chan CH; Cheng SC; Chan WH; Fung KS; Wong KY; Chan OMI; Man CW
    Ann Palliat Med; 2018 Jul; 7(3):320-331. PubMed ID: 29156920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Kiernan MC
    Med J Aust; 2005 Apr; 182(7):319-20. PubMed ID: 15804220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for motor neurone disease. More trials are needed.
    Sandercock J; Burls A; Hyde C; Fry-Smith A; Barton P; Bryan S; Stewart A
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403060
    [No Abstract]   [Full Text] [Related]  

  • 15. Riluzole for motor neurone disease. Reply from chairman of appraisal committee at NICE.
    Barnett D
    BMJ; 2001 Sep; 323(7312):573. PubMed ID: 11573490
    [No Abstract]   [Full Text] [Related]  

  • 16. Access to palliative care for people with motor neurone disease in New Zealand: a patient's perspective.
    Williams B
    N Z Med J; 2005 Oct; 118(1224):U1711. PubMed ID: 16258583
    [No Abstract]   [Full Text] [Related]  

  • 17. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Henderson RD; McCombe PA
    Med J Aust; 2005 Aug; 183(3):164; author reply 164-5. PubMed ID: 16053424
    [No Abstract]   [Full Text] [Related]  

  • 18. End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease.
    Cheng HWB; Chan OMI; Chan CHR; Chan WH; Fung KS; Wong KY
    Am J Hosp Palliat Care; 2018 Jun; 35(6):847-851. PubMed ID: 29034688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
    Mitchell JD; O'brien MR; Joshi M
    Amyotroph Lateral Scler; 2006 Jun; 7(2):67-71. PubMed ID: 16753969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of dysphagia in treating motor neurone disease.
    Vesey S
    Br J Community Nurs; 2017 Jul; 22(Sup7):S17-S21. PubMed ID: 28686046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.